PD-L1 status (PD-L1≧ 1% vs. < 1%) was predictive of ICI treatment response in brain metastases, but no significance was found between metastasis site and treatment response in the risk score (Fig. S6C, D). The gene discussed is CD274; the disease is metastasis.